Weighing the good and bad of GLP-1 weight-loss drugs

madman · Jan 31, 2026

* we discuss what a recently rolled-out GLP-1 pill, the first of its kind approved for obesity, could mean for the future of weight loss.

Drugs known as glucagon-like peptide-1 receptor agonists, colloquially called GLP-1 medications, have gone from relatively obscure diabetes treatments to blockbuster weight-loss medications. But is the hype backed up by science? In this episode, freelance science journalist Bethany Brookshire joins host Kendra Pierre-Louis to talk about how these drugs mimic natural hormones, why they’re so effective and what the latest research about their broader health effects says. Plus, we discuss what a recently rolled-out GLP-1 pill, the first of its kind approved for obesity, could mean for the future of weight loss.

madman · Jan 31, 2026

Thread 'Beyond the Needle: The Future of GLP-1 Pills and Other Emerging Obesity Treatments'

Dec 20, 2025

New drug candidates could transform the obesity treatment landscape again, as pill formulations and multi-agonist treatments undergo clinical trials. Endocrine Society experts Priya Jaisinghani, MD, DABOM, and Mehmet Furkan Burak, MD, discussed how emerging treatments could improve obesity treatment and provide new options for patients.

madman · Jan 31, 2026

Thread 'Semaglutide Forum: Game Changer for Weight Loss'

Mar 3, 2022

Mark A. Moyad, MD, MPH & Martin M. Miner, MD, discuss the potential benefits of semaglutide, a newly approved weight-loss drug.

Introduction: The Road to Real Weight Loss Solutions

Host:
This is another great segment with Dr. Marty Miner — physician extraordinaire, clinical professor of Family Medicine and Urology at Miriam Hospital, and one of the pioneering minds behind a legitimate men's health center at a major institution. He’s been doing this for decades, focusing on helping men improve their health—both mentally and physically.

If...